Does Hikma’s Vascepa Litigation Dismissal Suggest Safety For Skinny Labels?
GSK-Teva Rulings Had Been Seen As An Existential Threat To Indication Carve-Outs
Will skinny labels be shielded from the fallout of GSK-Teva? • Source: Federico Caputo / Alamy Stock Photo 
